Rositsa Mihaylova

32PUBLICATIONS
55CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular medicineMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 26, 2026
Design, Synthesis, and Integrated In Silico and In Vitro Evaluation of Chloro-Substituted Salicylaldehyde Benzoylhydrazones as Anticancer Agents.

|Jul 15, 2026
Asymmetrically Disubstituted Pyrenebutyrate Complexes of Pt(IV) as Cisplatin Prodrugs with Improved Anticancer Activity.

|May 27, 2026
Novel Cinnamaldehyde Hydrazones: Design, In Silico Evaluation, Synthesis, and Cytotoxic Activity.

|Mar 14, 2026
Emodin and the Anthraquinone Scaffold: Therapeutic Promise and Strategies to Overcome Translational Barriers.

Rositsa Mihaylova, Viktoria Elincheva, Rumyana Simeonova

|Feb 27, 2026
Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling.

Rositsa Mihaylova, Asine Dailova-Barzeva, Irena Philipova

|Feb 27, 2026
Erica spiculifolia Extract Potentiates Cisplatin Cytotoxicity by Reactivating p53 and Caspase-3-Dependent Apoptosis in Colorectal Carcinoma.

Rositsa Mihaylova, Nikolay Bebrivenski, Dimitrina Zheleva-Dimitrova

Pageof 6

Frequent Collaborators

12 joint publications

Georgi Momekov

11 joint publications

Dimitrina Zheleva-Dimitrova

11 joint publications

Rumyana Simeonova

7 joint publications

Reneta Gevrenova